|
TW574214B
(en)
|
1994-06-08 |
2004-02-01 |
Pfizer |
Corticotropin releasing factor antagonists
|
|
US7125880B1
(en)
|
1995-06-06 |
2006-10-24 |
Pfizer Inc. |
Corticotropin releasing factor antagonists
|
|
US6403599B1
(en)
|
1995-11-08 |
2002-06-11 |
Pfizer Inc |
Corticotropin releasing factor antagonists
|
|
WO1997049706A1
(en)
|
1996-06-25 |
1997-12-31 |
Novartis Ag |
SUBSTITUTED 7-AMINO-PYRROLO[3,2-d]PYRIMIDINES AND THE USE THEREOF
|
|
US5985848A
(en)
|
1997-10-14 |
1999-11-16 |
Albert Einstein College Of Medicine Of Yeshiva University |
Inhibitors of nucleoside metabolism
|
|
TW572758B
(en)
|
1997-12-22 |
2004-01-21 |
Sumitomo Pharma |
Type 2 helper T cell-selective immune response inhibitors comprising purine derivatives
|
|
US6187777B1
(en)
|
1998-02-06 |
2001-02-13 |
Amgen Inc. |
Compounds and methods which modulate feeding behavior and related diseases
|
|
US6232320B1
(en)
|
1998-06-04 |
2001-05-15 |
Abbott Laboratories |
Cell adhesion-inhibiting antiinflammatory compounds
|
|
CZ27399A3
(cs)
|
1999-01-26 |
2000-08-16 |
Ústav Experimentální Botaniky Av Čr |
Substituované dusíkaté heterocyklické deriváty, způsob jejich přípravy, tyto deriváty pro použití jako léčiva, farmaceutická kompozice a kombinovaný farmaceutický přípravek tyto deriváty obsahující a použití těchto derivátů pro výrobu léčiv
|
|
US20030187261A1
(en)
|
2000-01-07 |
2003-10-02 |
Libor Havlicek |
Purine derivatives, process for their preparation and use thereof
|
|
AU5919001A
(en)
|
2000-04-28 |
2001-11-12 |
Acadia Pharm Inc |
Muscarinic agonists
|
|
GB0114286D0
(en)
|
2001-06-12 |
2001-08-01 |
Hoffmann La Roche |
Nucleoside Derivatives
|
|
BR0211810A
(pt)
*
|
2001-08-09 |
2004-08-24 |
Ono Pharmaceutical Co |
Derivados ácido carboxìlico e agente farmacêutico compreendendo os mesmos como ingrediente ativo
|
|
TW200301251A
(en)
|
2001-12-20 |
2003-07-01 |
Wyeth Corp |
Azaindolylalkylamine derivatives as 5-hydroxytryptamine-6 ligands
|
|
RU2217159C1
(ru)
*
|
2002-03-18 |
2003-11-27 |
ООО "Содарм фарма" |
Раствор для ингаляций фармацевтической композиции глутовент и способ его терапевтического применения
|
|
EP1348707B1
(en)
|
2002-03-28 |
2010-08-25 |
Ustav Experimentalni Botaniky AV CR, v.v.i. (Institute of Experimental Botany Academy of Sciences of the Czech Republic, PRO) |
Pyrazolo[4,3-d]pyrimidines, processes for their preparation and methods for therapy
|
|
US20040063658A1
(en)
|
2002-05-06 |
2004-04-01 |
Roberts Christopher Don |
Nucleoside derivatives for treating hepatitis C virus infection
|
|
US6713241B2
(en)
|
2002-08-09 |
2004-03-30 |
Eastman Kodak Company |
Thermally developable emulsions and imaging materials containing binder mixture
|
|
ES2363766T3
(es)
|
2002-08-21 |
2011-08-16 |
Albert Einstein College Of Medicine Of Yeshiva University |
Inhibidores de nucleosidasas y fosforilasas de nucleosidos.
|
|
TWI349671B
(en)
|
2002-09-27 |
2011-10-01 |
Dainippon Sumitomo Pharma Co |
Novel adenine derivative and its use
|
|
US20060148805A1
(en)
|
2003-07-01 |
2006-07-06 |
Meng Hsin Chen |
Opthalmic compositions for treating ocular hypertension
|
|
WO2005020892A2
(en)
|
2003-08-08 |
2005-03-10 |
Mitochroma Research, Inc. |
Pharmaceutical compositions and methods for metabolic modulation
|
|
ES2342069T4
(es)
|
2003-09-05 |
2011-01-26 |
Anadys Pharmaceuticals, Inc. |
Ligandos de tlr7 para el tratamiento de la hepatitis c.
|
|
NZ546274A
(en)
|
2003-10-03 |
2009-12-24 |
3M Innovative Properties Co |
Pyrazolopyridines and analags thereof
|
|
PL1699512T3
(pl)
|
2003-11-03 |
2012-11-30 |
Glaxo Group Ltd |
Urządzenie do dozowania płynów
|
|
TWI392678B
(zh)
|
2004-03-26 |
2013-04-11 |
Dainippon Sumitomo Pharma Co |
９-取代-８-氧基腺嘌呤化合物
|
|
JPWO2005092892A1
(ja)
|
2004-03-26 |
2008-02-14 |
大日本住友製薬株式会社 |
８−オキソアデニン化合物
|
|
DE602005014964D1
(de)
|
2004-04-02 |
2009-07-30 |
Osi Pharm Inc |
Mit einem 6,6-bicyclischen ring substituierte heterobicyclische proteinkinaseinhibitoren
|
|
WO2005110410A2
(en)
|
2004-05-14 |
2005-11-24 |
Abbott Laboratories |
Kinase inhibitors as therapeutic agents
|
|
US20060029642A1
(en)
|
2004-08-03 |
2006-02-09 |
Dusan Miljkovic |
Methods and compositions for improved chromium complexes
|
|
GB0420719D0
(en)
|
2004-09-17 |
2004-10-20 |
Addex Pharmaceuticals Sa |
Novel allosteric modulators
|
|
EP1888587A1
(en)
|
2005-05-04 |
2008-02-20 |
Pfizer Limited |
2-amido-6-amino-8-oxopurine derivatives as toll-like receptor modulators for the treatment of cancer and viral infections, such as hepatitis c
|
|
NZ540160A
(en)
|
2005-05-20 |
2008-03-28 |
Einstein Coll Med |
Inhibitors of nucleoside phosphorylases
|
|
EP1915377A1
(en)
|
2005-07-22 |
2008-04-30 |
Sunesis Pharmaceuticals, Inc. |
Pyrazolo pyrimidines useful as aurora kinase inhibitors
|
|
CA2620182A1
(en)
|
2005-08-22 |
2007-03-01 |
Dennis A. Carson |
Tlr agonists
|
|
ATE517883T1
(de)
|
2005-08-25 |
2011-08-15 |
Schering Corp |
Imidazolderivate als funktionelle selektive agonisten des alpha2c-adrenorezeptors
|
|
US8003624B2
(en)
|
2005-08-25 |
2011-08-23 |
Schering Corporation |
Functionally selective ALPHA2C adrenoreceptor agonists
|
|
WO2007028129A1
(en)
|
2005-09-02 |
2007-03-08 |
Pfizer Inc. |
Hydroxy substituted 1h-imidazopyridines and methods
|
|
TW200801003A
(en)
|
2005-09-16 |
2008-01-01 |
Astrazeneca Ab |
Novel compounds
|
|
JPWO2007034817A1
(ja)
|
2005-09-22 |
2009-03-26 |
大日本住友製薬株式会社 |
新規アデニン化合物
|
|
EP1939201A4
(en)
|
2005-09-22 |
2010-06-16 |
Dainippon Sumitomo Pharma Co |
NEW ADENINE CONNECTION
|
|
WO2007034881A1
(ja)
|
2005-09-22 |
2007-03-29 |
Dainippon Sumitomo Pharma Co., Ltd. |
新規アデニン化合物
|
|
EP1939200A4
(en)
|
2005-09-22 |
2010-06-16 |
Dainippon Sumitomo Pharma Co |
NEW ADENINE CONNECTION
|
|
JPWO2007034882A1
(ja)
|
2005-09-22 |
2009-03-26 |
大日本住友製薬株式会社 |
新規アデニン化合物
|
|
TW200745114A
(en)
|
2005-09-22 |
2007-12-16 |
Astrazeneca Ab |
Novel compounds
|
|
CN1947717B
(zh)
|
2005-10-14 |
2012-09-26 |
卓敏 |
选择性抑制腺苷酸环化酶1的化合物在制备用于治疗神经性疼痛和炎性疼痛的药物中的应用
|
|
JP2009528989A
(ja)
|
2006-02-17 |
2009-08-13 |
ファイザー・リミテッド |
Ｔｌｒ７変調剤としての３−デアザプリン誘導体
|
|
EP2233472B1
(en)
|
2006-03-28 |
2014-01-15 |
Atir Holding S.A. |
Heterocyclic compounds and uses thereof in the treatment of sexual disorders
|
|
GB0610666D0
(en)
|
2006-05-30 |
2006-07-05 |
Glaxo Group Ltd |
Fluid dispenser
|
|
WO2007142755A2
(en)
|
2006-05-31 |
2007-12-13 |
The Regents Of The University Of California |
Purine analogs
|
|
US8138172B2
(en)
|
2006-07-05 |
2012-03-20 |
Astrazeneca Ab |
8-oxoadenine derivatives acting as modulators of TLR7
|
|
ES2437871T3
(es)
|
2006-07-07 |
2014-01-14 |
Gilead Sciences, Inc. |
Moduladores del receptor tipo toll 7
|
|
TW200831105A
(en)
|
2006-12-14 |
2008-08-01 |
Astrazeneca Ab |
Novel compounds
|
|
US20100120799A1
(en)
|
2007-02-19 |
2010-05-13 |
Smithkline Beecham Corporation |
Purine derivatives as immunomodulators
|
|
JP5480637B2
(ja)
|
2007-03-19 |
2014-04-23 |
アストラゼネカ・アクチエボラーグ |
Ｔｏｌｌ様受容体（ｔｌｒ７）モジュレーターとしての９−置換−８−オキソ−アデニン化合物
|
|
EP2139894B1
(en)
|
2007-03-19 |
2011-10-26 |
AstraZeneca AB |
9-substituted-8-oxo-adenine compounds as toll-like receptor (tlr7) modulators
|
|
US8044056B2
(en)
|
2007-03-20 |
2011-10-25 |
Dainippon Sumitomo Pharma Co., Ltd. |
Adenine compound
|
|
AR065784A1
(es)
|
2007-03-20 |
2009-07-01 |
Dainippon Sumitomo Pharma Co |
Derivados de 8-oxo adenina,medicamentos que los contienen y usos como agentes terapeuticos para enfermedades alergicas, antivirales o antibacterianas.
|
|
US7928111B2
(en)
|
2007-06-08 |
2011-04-19 |
Senomyx, Inc. |
Compounds including substituted thienopyrimidinone derivatives as ligands for modulating chemosensory receptors
|
|
JP5395068B2
(ja)
|
2007-06-29 |
2014-01-22 |
ギリアード サイエンシーズ， インコーポレイテッド |
トール様受容体７の調節物質としてのプリン誘導体およびその使用
|
|
GB0715087D0
(en)
|
2007-08-03 |
2007-09-12 |
Summit Corp Plc |
Drug combinations for the treatment of duchenne muscular dystrophy
|
|
US20090176778A1
(en)
|
2007-08-10 |
2009-07-09 |
Franz Ulrich Schmitz |
Certain nitrogen containing bicyclic chemical entities for treating viral infections
|
|
UY31531A1
(es)
|
2007-12-17 |
2009-08-03 |
|
Sales derivadas de 8-oxoadenina composiciones farmacéuticas que las contienen y su uso en terapia como moduladores de receptor tipo toll (tlr)
|
|
WO2009151910A2
(en)
|
2008-05-25 |
2009-12-17 |
Wyeth |
Combination product of receptor tyrosine kinase inhibitor and fatty acid synthase inhibitor for treating cancer
|
|
US8946239B2
(en)
|
2008-07-10 |
2015-02-03 |
Duquesne University Of The Holy Spirit |
Substituted pyrrolo, -furano, and cyclopentylpyrimidines having antimitotic and/or antitumor activity and methods of use thereof
|
|
WO2010018130A1
(en)
|
2008-08-11 |
2010-02-18 |
Smithkline Beecham Corporation |
Purine derivatives for use in the treatment of allergic, inflammatory and infectious diseases
|
|
US8802684B2
(en)
|
2008-08-11 |
2014-08-12 |
Glaxosmithkline Llc |
Adenine derivatives
|
|
WO2010018132A1
(en)
|
2008-08-11 |
2010-02-18 |
Smithkline Beecham Corporation |
Compounds
|
|
KR101616396B1
(ko)
|
2008-08-11 |
2016-04-28 |
글락소스미스클라인 엘엘씨 |
신규의 아데닌 유도체
|
|
UA103195C2
(uk)
|
2008-08-11 |
2013-09-25 |
Глаксосмитклайн Ллк |
Похідні пурину для застосування у лікуванні алергій, запальних та інфекційних захворювань
|
|
EA201100114A1
(ru)
|
2008-08-11 |
2011-10-31 |
ГЛАКСОСМИТКЛАЙН ЭлЭлСи |
Производные пурина для применения в лечении аллергических, воспалительных и инфекционных заболеваний
|
|
CN102548999A
(zh)
|
2009-01-20 |
2012-07-04 |
山东轩竹医药科技有限公司 |
含有取代的含氮稠杂环的头孢菌素衍生物
|
|
WO2010111406A2
(en)
|
2009-03-24 |
2010-09-30 |
Myriad Pharmaceuticals, Inc. |
Compounds and therapeutic uses thereof
|
|
CA2768195A1
(en)
|
2009-08-07 |
2011-02-10 |
Glaxosmithkline Biologicals Sa |
Lipidated oxoadenine derivatives
|
|
EA021048B1
(ru)
|
2010-02-10 |
2015-03-31 |
ГЛАКСОСМИТКЛАЙН ЭлЭлСи |
Малеат 6-амино-2-{[(1s)-1-метилбутил]окси}-9-[5-(1-пиперидинил)пентил]-7,9-дигидро-8н-пурин-8-она
|
|
US8575340B2
(en)
|
2010-02-10 |
2013-11-05 |
Glaxosmithkline Llc |
Purine derivatives and their pharmaceutical uses
|
|
WO2012009258A2
(en)
|
2010-07-13 |
2012-01-19 |
Edward Roberts |
Peptidomimetic galanin receptor modulators
|
|
WO2012092552A1
(en)
|
2010-12-30 |
2012-07-05 |
Selecta Biosciences, Inc. |
Synthetic nanocarriers with reactive groups that release biologically active agents
|
|
AU2012212323A1
(en)
|
2011-02-01 |
2013-09-12 |
The Board Of Trustees Of The University Of Illinois |
HDAC inhibitors and therapeutic methods using the same
|
|
WO2012106522A2
(en)
|
2011-02-04 |
2012-08-09 |
Duquesne University Of The Holy Spirit |
Bicyclic and tricyclic pyrimidine tyrosine kinase inhibitors with antitubulin activity and methods of treating a patient
|
|
PL2734186T3
(pl)
|
2011-07-22 |
2019-01-31 |
Glaxosmithkline Llc |
Kompozycja
|
|
JP6196674B2
(ja)
|
2012-08-24 |
2017-09-13 |
グラクソスミスクライン・リミテッド・ライアビリティ・カンパニーＧｌａｘｏＳｍｉｔｈＫｌｉｎｅ ＬＬＣ |
ピラゾロピリミジン化合物
|
|
US9550785B2
(en)
|
2012-11-20 |
2017-01-24 |
Glaxosmithkline Llc |
Pyrrolopyrimidines as therapeutic agents for the treatment of diseases
|
|
SMT201700378T1
(it)
|
2012-11-20 |
2017-09-07 |
Glaxosmithkline Llc |
Nuovi composti
|
|
KR20150085081A
(ko)
|
2012-11-20 |
2015-07-22 |
글락소스미스클라인 엘엘씨 |
신규 화합물
|
|
JP6452711B2
(ja)
|
2014-02-20 |
2019-01-16 |
グラクソスミスクライン、インテレクチュアル、プロパティー、（ナンバー２）、リミテッドＧｌａｘｏｓｍｉｔｈｋｌｉｎｅ Ｉｎｔｅｌｌｅｃｔｕａｌ Ｐｒｏｐｅｒｔｙ （Ｎｏ．２） Ｌｉｍｉｔｅｄ |
ヒトインターフェロンの誘導物質としてのピロロ［３，２］ピリミジン誘導体
|